M05BA Bisphosphonate drugs affecting bone structure and mineralization
M MUSCULO-SKELETAL SYSTEM DRUGS
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BA Bisphosphonate drugs affecting bone structure and mineralization
Medicines by ATC code M05BA Bisphosphonate drugs affecting bone structure and mineralization
- Zoledronic Acid Accord Patient leaflet Summary of medicine characteristics
- Iasibon Patient leaflet Summary of medicine characteristics
- Ibandronic acid Accord Patient leaflet Summary of medicine characteristics
- Zoledronic acid Actavis Patient leaflet Summary of medicine characteristics
- Zoledronic acid Mylan Patient leaflet Summary of medicine characteristics
- Zoledronic Acid Hospira Patient leaflet Summary of medicine characteristics
- Zoledronic acid Teva Patient leaflet Summary of medicine characteristics
- Aclasta Patient leaflet Summary of medicine characteristics
- Ibandronic Acid Teva Patient leaflet Summary of medicine characteristics
- Zometa Patient leaflet Summary of medicine characteristics
- Bonviva Patient leaflet Summary of medicine characteristics
- Bondronat Patient leaflet Summary of medicine characteristics
- Zoledronic acid medac Patient leaflet Summary of medicine characteristics
- Ibandronic Acid Sandoz Patient leaflet Summary of medicine characteristics
- Zoledronic acid Teva Pharma Patient leaflet Summary of medicine characteristics
- Zoledronic acid Teva Generics Patient leaflet Summary of medicine characteristics
- Bondenza (previously Ibandronic Acid Roche) Patient leaflet Summary of medicine characteristics
Other names of the ATC group
- Czech: M05BA Bisfosfonáty
- French: M05BA biphosphonates
- German: M05BA Bisphosphonate
- Spanish: M05BA BISFOSFONATOS (MEDICAM.CON EFECTO SOBRE MINERALIZACION OSEA)
- German: M05BA Bisphosphonate
- Italian: M05BA SODIO NERIDRONATO
- Polish: M05BA Bisfosfoniany
- Turkish: M05BA Kemik yapısını ve mineralizasyonunu etkileyen bifosfonat ilaçlar
- Portuguese (Brazil): M05BA Bifosfonatos